ICU Medical ICUI Infusion Consumables — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ICU Medical in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: ICU Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ICU Medical's infusion consumables — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ICU Medical's infusion consumables — revenue?
- ICU Medical (ICUI) reported infusion consumables — revenue of $278.28M in Q1 2026.
- How has ICU Medical's infusion consumables — revenue changed year-over-year?
- ICU Medical's infusion consumables — revenue increased by 4.5% year-over-year, from $266.23M to $278.28M.
- What is the long-term trend for ICU Medical's infusion consumables — revenue?
- Over 4 years (2021 to 2025), ICU Medical's infusion consumables — revenue has grown at a 18.9% compound annual growth rate (CAGR), from $555.19M to $1.11B.
- What does infusion consumables — revenue mean?
- This metric represents the total gross sales generated from the sale of single-use infusion therapy products, such as IV sets, connectors, and catheters. It serves as a primary indicator of market demand and adoption for the company's core disposable medical supplies within the infusion continuum. Tracking this revenue stream helps investors assess the stability and growth trajectory of the company's recurring product base.